Fármacos
{0>The European Medicine Agency, as of July 23, 2009, turned down the applications for both Lyrica (pregabalin)[58] and Savella (Impulsor; milnacipran) [59] for the fibromyalgia indication citing both the lack of efficacy and data on long-term effects.El 23 de julio de 2009, la Agencia Europea del Medicamento rechazó la solicitud de los ... ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.